SCHEMBL2273232

SCHEMBL2273232

Brc1cccc2snnc12

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GRM2 Q14416 9/20 0.34
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NQO2 P16083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29942154 1.00 BACE1 (0.35) BACE1MAPTL3MBTL1GRM2LMNA
Benzoic Acid SCHEMBL29120393 0.83 DAO (0.42) MAPTLMNAMEN1KMT2A
SCHEMBL28698487 0.82
SCHEMBL28682480 0.75 LMNA (0.33) LMNA
SCHEMBL5355939 0.74
SCHEMBL289345 0.74
SCHEMBL289346 0.74 ALDH1A1 (0.46) MAPT
SCHEMBL346282 0.74
SCHEMBL4615662 0.74 F9 (0.30)
SCHEMBL10591064 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514802-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2025-03-05 EP disclosed
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. 2024-02-22 US disclosed
WO-2023208986-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2023-11-02 WO disclosed
CN-111710802-B Display panel, preparation method of display panel and display device 云谷(固安)科技有限公司 2023-09-19 CN disclosed
CN-110734451-B Semiconductor material, preparation method thereof and organic light-emitting diode 北京大学深圳研究生院 2022-07-22 CN disclosed
CN-114163429-B Thermochromic material with single-crystal violet lactone structure, color developing composition, preparation method and application of thermochromic material 北京高德品创科技有限公司 2022-05-06 CN disclosed
CN-114163450-B Thermochromic material with single rhodamine structure, developing composition, preparation method and application thereof 北京高德品创科技有限公司 2022-05-06 CN disclosed
CN-114163450-A Thermochromic material with single rhodamine structure, developing composition, preparation method and application thereof 北京高德品创科技有限公司 2022-03-11 CN disclosed
CN-114163429-A Thermochromic material with single-crystal violet lactone structure, color developing composition, preparation method and application of thermochromic material 北京高德品创科技有限公司 2022-03-11 CN disclosed
US-20210323987-A1 Methods for the Synthesis of Heteroatom Containing Polycyclic Aromatic Hydrocarbons THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-10-21 US disclosed
WO-2007081991-A2 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-19 WO disclosed
WO-2007016392-A2 BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-08 WO disclosed
US-7138484-B2 Method for producing polymerized hydrocarbon JFE CHEMICAL CORPORATION (JP) 2006-11-21 US disclosed
US-20050075478-A1 Method for producing polymerized hydrocarbon JFE CHEMICAL CORPORATION (JP) 2005-04-07 US disclosed
EP-1520846-A1 Method for producing polymerized hydrocarbon JFE Chemical Corporation (JP) 2005-04-06 EP disclosed
US-4786739-A SULFIDING E. I. DUPONT DE NEMOURS AND COMPANY (US) 1988-11-22 US disclosed
EP-0146610-A4 SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES. DU PONT (US) 1986-02-20 EP disclosed
US-4571404-A PLANT HERBICIDE, FUNGICIDE OR VIRICIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-02-18 US disclosed
EP-0146610-A1 SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-07-03 EP disclosed
WO-1984004921-A1 SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES DU PONT (US) 1984-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323987-A1 Methods for the Synthesis of Heteroatom Containing Polycyclic Aromatic Hydrocarbons AHR, PAH, ALKBH3 BACE1 3878/4885MAPT 4225/4885L3MBTL1 3756/4885
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE KRAS, HRAS, APC BACE1 3827/4885MAPT 4629/4885L3MBTL1 4517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.